Citations 3
Comparison of Patients with Primary Hyperoxaluria 1 and Late-Stage CKD from the BONAPH1DE Registry and ILLUMINATE-C Lumasiran Trial
Baum, Michelle A. , Ben‐Shalom, Efrat , Belostotsky, Vladimir , Sellier-Leclerc, A.L., Du, W. J. , Kauf, Teresa L., Murphy, Michael Desmond, Groothoff, Jaap W. , Lieske, John C. , Knauf, Felix , Sellier‐Leclerc, Anne‐Laure , Du, Weiming, Callanan, Mary B.
Journal of the American Society of Nephrology | December 1, 2025 | Volume: 36 | Issue: 10S | Pages: No page available
Final 60-Month Efficacy, Safety, and Kidney Stone Outcomes of a Phase 3 Trial of Lumasiran for Primary Hyperoxaluria Type 1 in Infants and Young Children
Sas, David J. , Michael, Mini , Frishberg, Yaacov, Ben‐Shalom, Efrat , Shasha‐Lavsky, Hadas , Sellier-Leclerc, A.L., Hogan, Julien, Du, W. J. , Murphy, Michael Desmond, Kaspar, Cristin , Magen, Daniella , Hayes, Wesley Nathan , Sellier‐Leclerc, Anne‐Laure , Hogan, Julien , Du, Weiming
Journal of the American Society of Nephrology | October 23, 2025 | Volume: 36 | Issue: 10S | Pages: No page available
PHYOX3: Long-Term Safety and Efficacy of Nedosiran in Patients with Primary Hyperoxaluria Type 1
Iraola, María Gema Ariceta, Groothoff, Jaap W. , Lipkin, Graham, Moochhala, Shabbir H. , Sellier-Leclerc, A.L., Schalk, Gesa, Rawson, Verity, Torres, Sara Estupiñan, Zhou, Jing , Höppe, Bernd , Lieske, John C. , Lipkin, Graham W., Sellier‐Leclerc, Anne‐Laure
Journal of the American Society of Nephrology | October 28, 2024 | Volume: 35 | Issue: 10S | Pages: No page available